Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Torre-Amione

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Cardiac allograft hypertrophy: a new target for therapy, a surrogate marker for survival?G Torre-Amione
Current Opinion in Cardiology|June 8, 1999
The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatmentG Torre-Amione
Drug Safety|September 27, 2000
Comparative tolerability of the HMG-CoA reductase inhibitorsJ A Farmer, G Torre-Amione
Current Atherosclerosis Reports|March 20, 2001
The renin angiotensin system as a risk factor for coronary artery diseaseJ A Farmer, G Torre-Amione
Annals of Internal Medicine|July 15, 1994
Pitfalls in measuring cytokinesS Kapadia, G Torre-Amione, D L Mann
The American Journal of Pathology|April 1, 1990
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factorX M Sun, W Hsueh, G Torre-Amione
Cellular Immunology|November 1, 1989
Powerful immunosuppression mediated by interleukin 2-activated, nonantigen-specific, or H-2-restricted THY-1+ CD8+ cellsG Torre-Amione, R Tuetken, D A Rowley
Annals of the Rheumatic Diseases|December 1, 1999
Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failureG Torre-Amione, S S Stetson, J A Farmer
Drugs|May 10, 2000
Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implicationsG Torre-Amione, M T Vooletich, J A Farmer
Chest|January 1, 1996
Evolving concepts regarding selection of patients for cardiac transplantation. Assessing risks and benefitsG Torre-Amione, S Kapadia, D Short, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Cardiac allograft hypertrophy: a new target for therapy, a surrogate marker for survival?G Torre-Amione
Current Opinion in Cardiology|June 8, 1999
The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatmentG Torre-Amione
Drug Safety|September 27, 2000
Comparative tolerability of the HMG-CoA reductase inhibitorsJ A Farmer, G Torre-Amione
Current Atherosclerosis Reports|March 20, 2001
The renin angiotensin system as a risk factor for coronary artery diseaseJ A Farmer, G Torre-Amione
Annals of Internal Medicine|July 15, 1994
Pitfalls in measuring cytokinesS Kapadia, G Torre-Amione, D L Mann
The American Journal of Pathology|April 1, 1990
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factorX M Sun, W Hsueh, G Torre-Amione
Cellular Immunology|November 1, 1989
Powerful immunosuppression mediated by interleukin 2-activated, nonantigen-specific, or H-2-restricted THY-1+ CD8+ cellsG Torre-Amione, R Tuetken, D A Rowley
Annals of the Rheumatic Diseases|December 1, 1999
Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failureG Torre-Amione, S S Stetson, J A Farmer
Drugs|May 10, 2000
Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implicationsG Torre-Amione, M T Vooletich, J A Farmer
Chest|January 1, 1996
Evolving concepts regarding selection of patients for cardiac transplantation. Assessing risks and benefitsG Torre-Amione, S Kapadia, D Short, et al.
Pageof 5